Fresenius Must Sell Clinics To Finish $2B Liberty Buy: FTC

Law360, New York (February 28, 2012, 8:07 PM ET) -- The Federal Trade Commission will require Fresenius Medical Care AG & Co. to sell 60 outpatient dialysis clinics to resolve the FTC's claims that the company's proposed $2.1 billion acquisition of Liberty Dialysis Holdings Inc. would be anti-competitive, the agency said Tuesday.

Fresenius will have to divest clinics in 43 local markets in order to gain regulatory approval for the deal under a proposed consent order, the FTC said.

The company proposed to acquire Liberty for about $2.1 billion under an agreement dated Aug. 1, according...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers